A股異動 | 北方稀土(600111.SH)漲8% 單季利潤創歷史新高疊加券商看好
格隆匯1月14日丨北方稀土(600111.SH)漲7.9%,報44.28元,總市值1608.72億。公司公吿稱,預計2021年歸屬於上市公司股東的淨利潤與上年同期(法定披露數據)相比,將增加40.68億元到42.28億元,同比增加488.58%到507.79%。中泰證券指,公司21Q4單季度實現淨利潤17.52-19.12億元,環比增長57%-72%,創歷史新高。上調公司2022/2023年淨利潤分別為100、131億元(原盈利預測分別為95、126億元),按照1月13日收盤價,公司1491億市值計算,對應PE分別為30、15、11X,維持公司“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.